450 related articles for article (PubMed ID: 28383487)
1. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan MA; Azim S; Zubair H; Bhardwaj A; Patel GK; Khushman M; Singh S; Singh AP
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383487
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
3. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.
Tang YT; Xu XH; Yang XD; Hao J; Cao H; Zhu W; Zhang SY; Cao JP
World J Gastroenterol; 2014 Jul; 20(28):9405-17. PubMed ID: 25071335
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic targets for pancreatic cancer.
Tang SC; Chen YC
World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
[TBL] [Abstract][Full Text] [Related]
5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.
Takao S; Ding Q; Matsubara S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):614-20. PubMed ID: 22878838
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language.
Iguchi E; Safgren SL; Marks DL; Olson RL; Fernandez-Zapico ME
Yale J Biol Med; 2016 Dec; 89(4):575-590. PubMed ID: 28018146
[TBL] [Abstract][Full Text] [Related]
11. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
[TBL] [Abstract][Full Text] [Related]
12. Developments in miRNA gene signaling pathways in pancreatic cancer.
Vorvis C; Koutsioumpa M; Iliopoulos D
Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.
Neureiter D; Jäger T; Ocker M; Kiesslich T
World J Gastroenterol; 2014 Jun; 20(24):7830-48. PubMed ID: 24976721
[TBL] [Abstract][Full Text] [Related]
14. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
Reese M; Dhayat SA
J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding the molecular mechanism of pancreatic cancer metastasis.
Du YX; Liu ZW; You L; Wu WM; Zhao YP
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):361-70. PubMed ID: 27498575
[TBL] [Abstract][Full Text] [Related]
16. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
Gautam SK; Kumar S; Cannon A; Hall B; Bhatia R; Nasser MW; Mahapatra S; Batra SK; Jain M
Expert Opin Ther Targets; 2017 Jul; 21(7):657-669. PubMed ID: 28460571
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
19. The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure.
Lomberk GA; Urrutia R
Surg Clin North Am; 2015 Oct; 95(5):935-52. PubMed ID: 26315515
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
